Siplizumab for Sickle Cell Disease Transplant

Conditions: Anemia, Sickle Cell Interventions: Drug: Siplizumab; Procedure: Exchange Transfusion; Procedure: Total Body Irradiation; Procedure: Stem Cell Infusion; Drug: Cyclophosphamide 50mg; Drug: Mesna; Drug: Sirolimus Oral Tablet; Drug: Rituximab or Biosimilar Sponsors: Markus Mapara; ITB-Med LLC Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials